Advisor Group Holdings, Inc. Oncolytics Biotech Inc Transaction History

Advisor Group Holdings, Inc.

  • $67.1 Billion
  • Q3 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 63 shares of ONCY stock, worth $66. This represents 0.0% of its overall portfolio holdings.

Number of Shares
63
Previous 6,804 99.07%
Holding current value
$66
Previous $5,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$0.75 - $1.43 $5,055 - $9,639
-6,741 Reduced 99.07%
63 $0
Q2 2025

Sep 04, 2025
BUY
$0.33 - $0.77 $1,108 - $2,586
3,359 Added 97.5%
6,804 $5,000
Q2 2025

Aug 13, 2025
BUY
$0.33 - $0.77 $45 - $105
137 Added 4.14%
3,445 $2,000
Q1 2025

May 12, 2025
BUY
$0.55 - $0.93 $694 - $1,174
1,263 Added 61.76%
3,308 $1,000
Q4 2024

Jun 06, 2025
SELL
$0.74 - $1.4 $934 - $1,768
-1,263 Reduced 38.18%
2,045 $1,000
Q4 2024

Feb 07, 2025
SELL
$0.74 - $1.4 $4,774 - $9,032
-6,452 Reduced 75.93%
2,045 $1,000
Q2 2024

Aug 13, 2024
SELL
$0.99 - $1.24 $4,793 - $6,004
-4,842 Reduced 36.3%
8,497 $8,000
Q1 2024

May 10, 2024
BUY
$0.89 - $1.36 $3,673 - $5,612
4,127 Added 44.8%
13,339 $14,000
Q4 2023

Feb 12, 2024
SELL
$1.22 - $2.09 $610 - $1,045
-500 Reduced 5.15%
9,212 $12,000
Q3 2023

Nov 13, 2023
SELL
$1.98 - $3.24 $5,294 - $8,663
-2,674 Reduced 21.59%
9,712 $21,000
Q2 2023

Aug 10, 2023
SELL
$1.11 - $2.74 $250,522 - $618,407
-225,696 Reduced 94.8%
12,386 $32,000
Q1 2023

May 12, 2023
BUY
$1.2 - $1.91 $275,700 - $438,822
229,750 Added 2757.44%
238,082 $285,000
Q4 2022

Feb 10, 2023
BUY
$1.17 - $2.12 $985 - $1,785
842 Added 11.24%
8,332 $13,000
Q2 2022

Aug 10, 2022
SELL
$0.85 - $1.59 $447 - $837
-527 Reduced 6.57%
7,490 $8,000
Q1 2022

May 04, 2022
BUY
$1.31 - $2.02 $6,622 - $10,211
5,055 Added 170.66%
8,017 $11,000
Q3 2021

Nov 05, 2021
SELL
$1.93 - $2.77 $2,895 - $4,155
-1,500 Reduced 33.62%
2,962 $6,000
Q2 2021

Aug 02, 2021
BUY
$2.6 - $4.64 $1,300 - $2,320
500 Added 12.62%
4,462 $12,000
Q1 2021

May 13, 2021
BUY
$2.32 - $4.11 $2,320 - $4,110
1,000 Added 33.76%
3,962 $16,000
Q4 2020

Feb 10, 2021
SELL
$1.71 - $4.03 $114 - $270
-67 Reduced 2.21%
2,962 $7,000
Q2 2020

Aug 14, 2020
SELL
$1.33 - $2.76 $9,336 - $19,375
-7,020 Reduced 69.86%
3,029 $6,000
Q1 2020

May 18, 2020
BUY
$0.98 - $4.28 $9,848 - $43,009
10,049 New
10,049 $13,000

Others Institutions Holding ONCY

# of Institutions
58
Shares Held
2.82M
Call Options Held
0
Put Options Held
0
View Full List

About ONCOLYTICS BIOTECH INC

ONCY Quotes by TradingView
  • Ticker ONCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,867,400
  • Market Cap $60.8M
  • Description
  • Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...
More about ONCY
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email